FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
NITROGEN, NF
nitrogen
Peak
Universal Cells
INHALATION · GAS
2018
NDA30/100
NITROGEN, NF
nitrogen
Peak
INHALATION · GAS
2013
NDA30/100
NITROGEN, NF
nitrogen
Peak
INHALATION · GAS
2013
NDA30/100
NITROGEN, NF
nitrogen
Peak
INHALATION · GAS
2013
NDA30/100
NITROUS OXIDE, USP
nitrous oxide
Peak
Advanced Solutions Life Sciences
INHALATION · GAS
2013
NDA30/100
NITROUS OXIDE, USP
nitrous oxide
Peak
Medica Corp
INHALATION · GAS
2014
NDA30/100
NITROUS OXIDE, USP
nitrous oxide
Peak
INHALATION · GAS
2013
NDA30/100
NITROUS OXIDE, USP
nitrous oxide
Peak
INHALATION · GAS
2013
NDA30/100
NITROUS OXIDE, USP
nitrous oxide
Peak
INHALATION · GAS
2017
NDA30/100
NITROUS OXIDE, USP
nitrous oxide
Peak
INHALATION · GAS
2017
NDA30/100
NORTHERA
droxidopa
Peak
ORAL · CAPSULE
orthostatic dizzinesslightheadedness+5
2014
NDA30/100
NORVIR
ritonavir
Peak
AbbVie
ORAL · POWDER
2017
SMNDA30/100
NOXAFIL POWDERMIX KIT
posaconazole
Peak
Merck & Co.
ORAL · FOR SUSPENSION, DELAYED RELEASE
invasive aspergillosisolder+11
2021
SMNDA30/100
Nitrogen, NF
nitrogen
Peak
INHALATION · GAS
2022
NDA30/100
Nitrogen, NF
nitrogen
Peak
Advanced Solutions Life Sciences
INHALATION · GAS
2020
NDA30/100
OMTRYG
omega-3-acid ethyl esters type a
Peak
ORAL · CAPSULE
2014
NDA30/100
ONFI
clobazam
Peak
ORAL · SUSPENSION
2012
NDA30/100
ONFI
clobazam
Peak
ORAL · TABLET
2011
NDA30/100
ORALTAG
iohexol
Peak
R-Pharm US
ORAL · FOR SOLUTION
2015
NDA30/100
OTEZLA
apremilast
Peak
Bristol Myers Squibb
ORAL · TABLET
2014
NDA30/100
OXAYDO
oxycodone hydrochloride
Peak
ORAL · TABLET
acutechronic pain severe enough to require an opioid analgesic+1
2011
NDA30/100
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
Peak
KalVista Pharmaceuticals
ORAL · SOLUTION
2012
NDA30/100
OXYGEN, USP
oxygen
Peak
INHALATION · GAS
2013
NDA30/100
OXYGEN, USP
0xygen
Peak
INHALATION · GAS
2013
NDA30/100